News wire

GLP-1 Vision Loss (NAION)

Stories that name GLP-1 Vision Loss (NAION).

View mdl profile

Source check 2 min ago · Newest item 7 hr ago · 1,441 stories this week · 87 of 90 publishers answering · Browse publishers · RSS feed

PI DATA HUBLegal intelligence
Filter stories

GLP-1 Vision Loss (NAION)

Monday, November 16

Announcement Illinois Lawyer Now (ISBA)IL

Ozempic and Vision Loss: What the FDA’s New NAION Warning Means in Illinois

On November 9, 2026, the FDA ordered every company that sells a GLP-1 drug to add a new warning to its label: a possible increased risk of NAION, a rare eye condition that can cause sudden and sometimes permanent vision loss. The order covers Ozempic, Wegovy, Mounjaro, Zepbound and every other GLP-1 on the market.... Continue Reading

Read at Illinois Lawyer Now (ISBA)

Friday, November 13

Announcement Illinois Lawyer Now (ISBA)IL

Illinois Medicaid Filled Nearly 1 Million Prescriptions for Leading GLP-1 Drugs Before the FDA’s Vision Loss Warning

Illinois Medicaid paid for 993,119 prescriptions for nine leading GLP-1 drugs between 2022 and 2025, at a gross cost of $1.1 billion. Every one was filled before November 9, 2026, when the FDA ordered manufacturers to add a warning about a rare form of permanent vision loss called NAION. Ankin Law analyzed four years of... Continue Reading

Read at Illinois Lawyer Now (ISBA)

Wednesday, November 11

Monday, November 9

Friday, October 30

Tuesday, October 13

Monday, October 5

Connect the news to your market.

Research the firms, offices and conference relationships behind the headlines.

Request research access